Lupin Pharmaceuticals has received the nod from the US FDA for its Minocycline hydrochloride extended release tablets 45 mg, 55 mg, 90 mg and 135 mg strengths.
Lupin Pharmaceuticals has received the nod from the US FDA for its Minocycline hydrochloride extended release tablets 45 mg, 55 mg, 90 mg and 135 mg strengths. Lupin has also received tentative approval for its Minocycline HCI extended release tablets 65 mg, 80 mg, 105 mg and 115 mg strengths.
Solodyn is an oral antibiotic used in the treatment of red, pus-filled pimples and acne in patients 12 years of age and older.
Source-Medindia